Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-04

Clinical Trial Update: Neoadjuvant Radiotherapy for HCC Involving Type I PVTT [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial update on neoadjuvant radiotherapy for hepatocellular carcinoma involving Type I portal vein tumor thrombus (PVTT).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: UNKNOWN